4 Results for "

LSD1-CoREST enzymatic complex

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "LSD1-CoREST enzymatic complex" in MCE Product Catalog:

Cat. No.: HY-175184
Target:  

Histone Demethylase

Research Areas:  

Infection

LSD1-IN-44 (Compound 19) is a LSD1 inhibitor with an IC50 of 0.02  μM for LSD1-CoREST enzymatic complex. LSD1-IN-44 has significant antischistosomal activity against transformed schistosomula (NTS) and Schistosoma mansoni adult worms while showing a delayed onset of action towards juvenile forms. LSD1-IN-44 has no significant toxicity to human cells. LSD1-IN-44 can be used for schistosomiasis research .
loading...
    loading...
Cat. No.: HY-175185
Target:  

Histone Demethylase

Research Areas:  

Infection

MC3935 is a LSD1 inhibitor with an IC50 of 0.52  μM for LSD1-CoREST enzymatic complex. MC3935 has significant antischistosomal activity against transformed schistosomula (NTS) and Schistosoma mansoni adult worms while showing a delayed onset of action towards juvenile forms. MC3935 has no significant toxicity to human cells. MC3935 can be used for schistosomiasis research .
loading...
    loading...
Cat. No.: HY-161848
Target:  

Histone Demethylase

Research Areas:  

Cancer

TCP-MP-CA (compound 11a) is an inhibitor of LSD1 demethylation enzymatic via binding to LSD1/CoREST complex. TCP-MP-CA exhibits an inhibitory effect on osteoclastogenesis, with an IC50 value of 0.14 µM .
loading...
    loading...
Cat. No.: HY-161849
Target:  

Histone Demethylase

Research Areas:  

Metabolic Disease

LSD1-IN-31 (compound 11e) can directly bind to LSD1/CoREST complex to reduce LSD1 demethylation enzymatic activity. LSD1-IN-31 inhibits LSD1 demethylation activity and influences its downstream IκB/NF-κB signaling pathway. LSD1-IN-31 inhibits osteoclastic bone loss in vitro and in vivo. LSD1-IN-31 can be used for osteoporosis research .
loading...
    loading...